NasdaqGS:GHHealthcare
Is Guardant Health’s (GH) Shield Tour Redefining Its Competitive Moat in Cancer Screening?
Earlier this month, Guardant Health launched Shield Across America, a coast-to-coast mobile tour bringing its FDA-approved Shield blood test for primary colorectal cancer screening directly to more than 100 communities, with a focus on underserved rural areas and screening-eligible adults.
By combining this outreach with strong survey support for blood-based screening, updated National Comprehensive Cancer Network guidelines, and broad public payer coverage, Guardant is working to reduce...